Pictet Asset Management Holding Sa Zai Lab LTD Transaction History

Pictet Asset Management Holding Sa

  • $88 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$13.72 - $21.55 $60,971 - $95,768
4,444 New
4,444 $77,000
Q4 2023

Feb 13, 2024
BUY
$22.97 - $30.58 $716,664 - $954,096
31,200 Added 13.02%
270,776 $7.4 Million
Q3 2023

Nov 14, 2023
BUY
$22.72 - $31.49 $5.44 Million - $7.54 Million
239,576 New
239,576 $5.82 Million

Others Institutions Holding ZLAB

# of Institutions
122
Shares Held
46.7M
Call Options Held
223K
Put Options Held
588K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.73B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email